<p>Naomi Schwartz, the Senior Director for Cybersecurity Quality & Safety at Medcrypt, a medical device cybersecurity specialty firm, shares some interesting tidbits about FDA's upcoming Refuse-to-Accept (RTA) policy for Cyber Devices and Related Systems. The policy is effective Oct. 1 and Schwartz breaks down what the RTA will mean for medical device manufacturers and their FDA submissions. </p>

Naomi Schwartz, the Senior Director for Cybersecurity Quality & Safety at Medcrypt, a medical device cybersecurity specialty firm, shares some interesting tidbits about FDA's upcoming Refuse-to-Accept (RTA) policy for Cyber Devices and Related Systems. The policy is effective Oct. 1 and Schwartz breaks down what the RTA will mean for medical device manufacturers and their FDA submissions.

<p>Naomi Schwartz, the Senior Director for Cybersecurity Quality &amp; Safety at Medcrypt, a medical device cybersecurity specialty firm, shares some interesting tidbits about FDA's upcoming Refuse-to-Accept (RTA) policy for Cyber Devices and Related Systems. The policy is effective Oct. 1 and Schwartz breaks down what the RTA will mean for medical device manufacturers and their FDA submissions. </p>

Decrypting FDA's Cybersecurity Policy

MD+DI editors discuss current trends in the medical device and diagnostics industry, and point out developments to watch in the coming months.

Share Decrypting FDA's Cybersecurity Policy

Sign up to save your podcasts

Decrypting FDA's Cybersecurity Policy

Decrypting FDA's Cybersecurity Policy

More shows like Let’s Talk Medtech

The Daily